Results 191 to 200 of about 7,072 (218)
Some of the next articles are maybe not open access.
[Heart failure with reduced left ventricular ejection fraction (HFrEF, HFmrEF)].
Therapeutische Umschau. Revue therapeutiqueHeart failure is the final stage of most heart diseases and, with over 64 million people affected worldwide, is considered a global pandemic. The prevalence is expected to continue to rise. The prevention and treatment of cardiovascular diseases and the early detection of patients suffering from heart failure are essential.
Thomas, Seiler, Matthias, Paul
openaire +1 more source
Heart failure with mid-range or mildly reduced ejection fraction
Nature Reviews Cardiology, 2021Gianluigi Savarese +2 more
exaly
Dapagliflozin wirkt bei HFpEF und HFmrEF Glykämie-unabhängig
Diabetologie und Stoffwechsel, 2023openaire +1 more source
Who wants the middle seat?: HFmrEF in a world dominated by HFpEF and HFrEF
Journal of Cardiac Failure, 2023Peter M, Eckman, Ruben, Crespo
openaire +2 more sources
CLINICAL PREDICTORS OF ONE-YEAR TRAJECTORY OF EJECTION FRACTION IN PATIENTSWITH HFMREF
Journal of the American College of Cardiology, 2023Apoorva Gangavelli +6 more
openaire +1 more source
How to Measure DELIVERed Benefits of Dapagliflozin in the Management of HFmrEF/HFpEF?
JACC: Heart Failure, 2023Atsushi Tanaka +2 more
openaire +2 more sources